Quick Takeaways: Why It Matters? MUMS status gives Masivet a clearer US regulatory and commercial path, adding potential 7‑year market exclusivity and grant support on top of its established European use, which should enhance the asset’s value as AB Science courts par...
Quick Takeaways: Why It Matters? Data for LPT‑CBD strengthens the scientific case for long‑acting, injectable CBD as a legitimate chronic pain option, not just a wellness supplement, which can increase veterinarian openness to cannabinoid-based therapies. The sustaine...
Quick Takeaways Why It Matters? Kradle extends its brand from dogs into the under-served feline calming space, broadening its emotional wellness reach. The non-sedating, hemp-plus-herbs formula differentiates it from generic calming oils and treats. Covering bot...
Quick Takeaways: Why It Matters? The deal broadens Greenies’ reach in the vet channel, making it easier for clinics to stock dental treats and Pill Pockets as everyday compliance tools. By adding a major brand, epiq enhances its importance as a distribution partn...
Quick Takeaways: Why It Matters? The recall may temporarily weaken confidence in Neogen’s veterinary portfolio and open space for rival hyaluronate or wound-care products. It also underscores regulatory and safety scrutiny around off-label use, likely prompting v...
Quick Takeaways: Why It Matters? Full approval and label expansion make Vetmedin the standard of care for early-stage MMVD, locking in pimobendan as the only FDA‑approved option for delaying CHF in Stage B2 dogs and driving guideline‑aligned, earli...
Quick Takeaways: Why It Matters? The deal adds another science‑forward brand to epiq’s portfolio and deepens its role as a specialty distributor that can take microbiome‑based innovations from H&H/Zesty Paws into the vet channel with supply-chain and market‑access...
Quick Takeaways: Why It Matters? By adding a feline‑specific soft chew built on proprietary CBD + CBDA data, ElleVet deepens its position as a science‑led cannabinoid brand and expands use beyond dogs into a harder‑to‑treat cat population. The palatable, lo...
Quick Takeaways: Why It Matters? By expanding Cancer Dx and inVue Dx, IDEXX tightens its grip on veterinary oncology workflows, nudging clinics toward proactive, panel-based cancer screening rather than reactive testing. Bundling mast cell detection at no extra c...
Quick Takeaways: Why It Matters? The DR50 Plus strengthens IDEXX’s imaging ecosystem, giving clinics a premium option that combines lower dose with sharper, AI-optimized images. Dose reduction and fewer retakes can improve staff and patient safety, while tighter ...
